Meeder Asset Management Inc Novo Nordisk A S Transaction History

Meeder Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $35,539 - $43,614	373 Added 296.03%	499 $50,000
Q2 2022 Aug 08, 2022	SELL	$103.24 - $121.81 $96,116 - $113,405	-931 Reduced 88.08%	126 $14,000
Q1 2022 May 10, 2022	SELL	$93.1 - $112.54 $35,564 - $42,990	-382 Reduced 26.55%	1,057 $117,000
Q3 2021 Nov 08, 2021	BUY	$84.42 - $106.62 $29,884 - $37,743	354 Added 32.63%	1,439 $138,000
Q2 2021 Aug 09, 2021	BUY	$67.66 - $84.76 $35,859 - $44,922	530 Added 95.5%	1,085 $91,000
Q1 2021 Apr 28, 2021	BUY	$67.06 - $75.82 $34,401 - $38,895	513 Added 1221.43%	555 $37,000
Q4 2020 Feb 09, 2021	BUY	$63.89 - $73.8 $1,533 - $1,771	24 Added 133.33%	42 $3,000
Q3 2020 Nov 02, 2020	BUY	$63.69 - $70.22 $1,146 - $1,263	18 New	18 $1,000

1,955

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.